Prosecution Insights
Last updated: November 04, 2026
Application No. 18/293,596

Medical device and method for safely closing, isolating, or adjusting the volume of a structure in the human body

Final Rejection §103§112
Filed
Jan 30, 2024
Priority
Aug 03, 2022 — WO PCT/US2022/039298 +1 more
Examiner
DAVID, SHAUN L
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Eleftherios Basilios Sideris
OA Round
2 (Final)
73%
Grant Probability
Favorable
3-4
OA Rounds
9m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
435 granted / 598 resolved
+2.7% vs TC avg
Strong +18% interview lift
Without
With
+18.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
33 currently pending
Career history
639
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
39.2%
-0.8% vs TC avg
§102
23.9%
-16.1% vs TC avg
§112
25.7%
-14.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 598 resolved cases

Office Action

§103 §112
DETAILED ACTION This Office Action is a Response to Applicant’s Arguments and Amendment submitted 12/22/2025. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections The objection to claim(s) 6 in the previous Office Action for informalities is hereby withdrawn in view of Applicant’s Amendment. Claim Rejections - 35 USC § 112 The rejection of claim(s) 2-6 in the previous Office Action under this section, 2nd paragraph (pre-AIA ) or subsection (b) (AIA ), for being indefinite is hereby withdrawn in view of Applicant’s Amendment. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 9 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 9, the claim recites that the component for controlled deflation is coated by an insulating material. Claim 1, as amended, recites a variety of structures which constitute the component for controlled deflation, including, inter alia, a user interface. It is unclear how a user interface can be coated by an insulating material, therefore rendering the claim indefinite. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-4, 6, 7, 9-13, and 14 is/are rejected under 35 U.S.C. 103 as being unpatentable US 2013/0338696 A1 to Sideris (hereinafter “Sideris”) in view of US 4,545,367 to Tucci (hereinafter “Tucci”). Regarding claim 1, Sideris discloses (see abstract; Figs. 1-10; and [0026]-[0038]) a device (Figs. 8-10, [0033]) comprising an occluding segment (see [0033] and Fig. 8, 9 + 13), wherein the occluding segment contains one or more inflatable members (13, see Fig. 8 and see [0033]), the occluding segment contains at least one component that enables controlled deflation (see [0033]) of at least one inflatable member following permanent implantation of the device (see [0033]); a delivery segment (11) wherein the delivery segment contains at least one lumen (an inflation lumen is inherent in the device of Fig. 8 in order to inflate balloon 13) to accommodate inflation of at least one inflatable member and the delivery segment is detachably coupled to the occluding segment on at least one point (see [0033]-[0035] and Fig. 9); wherein the inflatable members are surrounded by a material (9) intended to achieve a result of accelerated permanent attachment to the surrounding tissue and/or accelerated endothelialization (see [0033]). Sideris further discloses (claim 2) wherein at least one inflatable member contains at least one valve (see [0037]); (claim 3) wherein the at least one inflatable member is attached to at least one stem-like member on at least one point (see [0035], portion of catheter portion 11 received within hole in neck 12, see also Fig. 8); (claim 4) whereby each inflatable member can be inflated/deflated independently (see [0035]); (claim 6) wherein the material forms a patch, wherein the patch is attached to at least one inflatable member on at least one point, the patch is elastic; and the patch is porous (see Figs. 8-9 and [0033]); (claim 10) wherein the occluding segment and delivery segment maintain alignment throughout deployment (see Figs. 7-9); and (claim 11) wherein the delivery segment incorporates a steerable mechanism (see [0035]). Regarding claim 7, Sideris discloses (see abstract; Figs. 1-10; and [0026]-[0038]) a device (Figs. 8-10, [0033]) comprising an occluding segment (see [0033] and Fig. 8, 9 + 13), wherein the occluding segment contains one or more inflatable members (13, see Fig. 8 and see [0033]), the occluding segment contains at least one component that enables controlled deflation (see [0033]) of at least one inflatable member following permanent implantation of the device (see [0033]); a delivery segment (11) wherein the delivery segment contains at least one lumen (an inflation lumen is inherent in the device of Fig. 8 in order to inflate balloon 13) to accommodate inflation of at least one inflatable member and the delivery segment is detachably coupled to the occluding segment on at least one point (see [0033]-[0035] and Fig. 9); and wherein the occluding segment accommodates a guide wire for 'over the wire' implantation (see Fig. 7). Regarding claim 14, Sideris discloses (see abstract; Figs. 1-10; and [0026]-[0038]) a method of placing a device (Figs. 8-10, [0033]-[0035]) at the site of a physiological structure (ASD shown in Fig. 9) comprising: a. placing into a delivery sheath ("long sheath", [0035]) an occluding segment (see [0033] and Fig. 8, 9 + 13) that is detachably coupled to a delivery segment (11, see Figs. 8-9 and [0033]-[0035]), wherein said occluding segment contains at least one inflatable member (13, see Fig. 8 and [0033]) and at least one component that enables controlled deflation (see [0033], bio-degradable barrier of the balloon which degrades under physiological conditions to cause deflation and thus corresponds under 112f to the structure for performing the claimed function) of the at least one inflatable member following permanent implantation of the device (see [0033]) b. advancing the occluding segment through the delivery sheath to the physiological structure of interest via the delivery segment (see [0035]); c. inflating the at least one inflatable member of the occluding segment (see [0035]); d. detaching the occluding segment from the delivery segment (see [0033]/[0035]); and e. deflating the at least one member (see [0033]). Regarding claims 1, 7 and 14, Sideris fails to specifically disclose wherein the component for controlled deflation takes a form selected from the group consisting essentially of: a. an actuation system that incorporates at least one of the following features: i. an actuator; ii. a receiver; iii. a transmitter/transducer; iv. an electronic circuit; v. a power source; vi. a sensor; vii. a user interface; or b. a valve mechanism that changes state based on crossing a threshold of mechanical forces set by the deployed configuration of at least one inflatable member of the occluding segment. Note that Sideris discloses that once the supporting function of the balloon is no longer necessary, it is deflated actively or passively in order for the device volume to be reduced to the size that is necessary for effective occlusion (see [0033]), but fails to specify any particular mechanism for actively deflating the balloon, therefore inferring that any known mechanism for actively deflating the balloon would be suitable for use. Tucci discloses, in the same field of endeavor, a device comprising: an occluding segment (102), wherein the occluding segment contains one or more inflatable members (112), the occluding segment contains at least one component that enables controlled deflation of at least one inflatable member following permanent implantation of the device (see Col. 12, lines 30-36 & Col. 11, lines 12-16); and, a delivery segment (16) wherein the delivery segment contains at least one lumen to accommodate inflation of at least one inflatable member and the delivery segment is detachably coupled to the occluding segment on at least one point (see Figs. 3-6 and Col. 9, lines 22-43) wherein the component for controlled deflation is an actuation system incorporating an actuator (knob 172) (see Col. 12, lines 30-36). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention, as a matter of applying a known technique to a known device/method ready for improvement to yield predictable results (see KSR International Co. v. Teleflex Inc., 550 U.S. 398,82 USPQ2d 1385,1395- 97(2007)), to obtain the predictable result of a mechanism suitable for actively deflating the implanted occluding/balloon member, with a reasonable expectation of success, since Sideris does not disclose any specific active deflation mechanism and therefore one of ordinary skill would understand that any suitable mechanism for active deflation known in the art would be suitable, and Tucci discloses a suitable active deflation mechanism comprising an actuation system incorporating an actuator that would be suitable for use with a reasonable expectation of success in making the proposed combination to one of ordinary skill in the art. The combination of Sideris and Tucci, as discussed above for the reasons set forth above, would further disclose (claim 9) wherein the component for controlled deflation is coated by an insulating material (see Fig. 9 of Tucci, knurled knob 172 comprises an insulating material coating); (claim 12) wherein the delivery segment incorporates at least one pressure sensor (see Col. 12, lines 10-29 of Tucci) and (claim 13) whereby the component for controlled deflation can be activated by an external controller (any type of external controller is capable of grasping and rotating knurled knob 172 of Tucci). Response to Arguments Applicant’s arguments with respect to claim(s) 1-4, 6, 7, 9-13, and 14 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHAUN L DAVID whose telephone number is (571)270-5263. The examiner can normally be reached M-F 10AM-6:30PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Darwin Erezo can be reached at 571-272-4695. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHAUN L DAVID/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jan 30, 2024
Application Filed
Jul 10, 2025
Non-Final Rejection mailed — §103, §112
Oct 10, 2025
Response Filed
Oct 10, 2025
Response after Non-Final Action
Dec 22, 2025
Response Filed
Aug 12, 2026
Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778588
APPARATUS AND METHOD FOR ENDOSCOPIC ANASTOMOSIS OF THE STOMACH AND THE BOWEL
3y 1m to grant Granted Nov 03, 2026
Patent 12773203
SURGICAL CONSTRUCTS AND METHODS OF TISSUE REPAIR
2y 11m to grant Granted Oct 27, 2026
Patent 12758208
SUTURE BUTTON AND METHODS
2y 8m to grant Granted Oct 13, 2026
Patent 12758222
TISSUE ALIGNMENT FOR SURGICAL CLOSURE
2y 11m to grant Granted Oct 13, 2026
Patent 12758209
KNOTLESS ANCHOR
2y 6m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
73%
Grant Probability
91%
With Interview (+18.4%)
3y 6m (~9m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 598 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month